 | • レポートコード：D0804-11253 • 出版社/出版日：GlobalInfoResearch / 2020年8月3日 ※2025年版があります。お問い合わせください。 • レポート形態：英語、PDF、106ページ • 納品方法：Eメール • 産業分類：医薬品・治療 |
| Single User | ￥487,200 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥730,800 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥974,400 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、網膜用治療薬の世界市場を広く調査・分析し、今後の市場展望をまとめております。網膜用治療薬の種類別市場規模（湿性AMD、糖尿病性網膜症、DME、RVO、Mcnv）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Bayer、ThromboGenics、Regeneron、F. Hoffmann-La Roche、Teva Pharmaceutical、Novartis、Takeda、Merck ・地域別グローバル市場分析 2015年-2020年 ・網膜用治療薬の北米市場（アメリカ、カナダ、メキシコ） ・網膜用治療薬のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・網膜用治療薬のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・網膜用治療薬の南米市場（ブラジル、アルゼンチン） ・網膜用治療薬の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：湿性AMD、糖尿病性網膜症、DME、RVO、Mcnv ・用途別分析：病院、クリニック、その他 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Retinal Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Retinal Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Retinal Drugs market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Retinal Drugs market has been segmented into
Wet AMD
Diabetic Retinopathy
DME
RVO
Mcnv
By Application, Retinal Drugs has been segmented into:
Hospitial
Clinicl
Others
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Retinal Drugs market presented in the report. This section sheds light on the sales growth of different regional and country-level Retinal Drugs markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Retinal Drugs market.
The report offers in-depth assessment of the growth and other aspects of the Retinal Drugs market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Retinal Drugs Market Share Analysis
Retinal Drugs competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Retinal Drugs sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Retinal Drugs sales, revenue and market share for each player covered in this report.
The major players covered in Retinal Drugs are:
Bayer
ThromboGenics
Regeneron
F. Hoffmann-La Roche
Teva Pharmaceutical
Novartis
Takeda
Merck
Among other players domestic and global, Retinal Drugs market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Retinal Drugs product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Retinal Drugs, with price, sales, revenue and global market share of Retinal Drugs in 2018 and 2019.
Chapter 3, the Retinal Drugs competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Retinal Drugs breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Retinal Drugs market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Retinal Drugs sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Retinal Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Retinal Drugs Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Wet AMD
1.2.3 Diabetic Retinopathy
1.2.4 DME
1.2.5 RVO
1.2.6 Mcnv
1.3 Market Analysis by Application
1.3.1 Overview: Global Retinal Drugs Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitial
1.3.3 Clinicl
1.3.4 Others
1.4 Overview of Global Retinal Drugs Market
1.4.1 Global Retinal Drugs Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Bayer
2.1.1 Bayer Details
2.1.2 Bayer Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Bayer SWOT Analysis
2.1.4 Bayer Product and Services
2.1.5 Bayer Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 ThromboGenics
2.2.1 ThromboGenics Details
2.2.2 ThromboGenics Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 ThromboGenics SWOT Analysis
2.2.4 ThromboGenics Product and Services
2.2.5 ThromboGenics Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Regeneron
2.3.1 Regeneron Details
2.3.2 Regeneron Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Regeneron SWOT Analysis
2.3.4 Regeneron Product and Services
2.3.5 Regeneron Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 F. Hoffmann-La Roche
2.4.1 F. Hoffmann-La Roche Details
2.4.2 F. Hoffmann-La Roche Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 F. Hoffmann-La Roche SWOT Analysis
2.4.4 F. Hoffmann-La Roche Product and Services
2.4.5 F. Hoffmann-La Roche Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Teva Pharmaceutical
2.5.1 Teva Pharmaceutical Details
2.5.2 Teva Pharmaceutical Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Teva Pharmaceutical SWOT Analysis
2.5.4 Teva Pharmaceutical Product and Services
2.5.5 Teva Pharmaceutical Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.6 Novartis
2.6.1 Novartis Details
2.6.2 Novartis Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 Novartis SWOT Analysis
2.6.4 Novartis Product and Services
2.6.5 Novartis Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.7 Takeda
2.7.1 Takeda Details
2.7.2 Takeda Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Takeda SWOT Analysis
2.7.4 Takeda Product and Services
2.7.5 Takeda Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.8 Merck
2.8.1 Merck Details
2.8.2 Merck Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 Merck SWOT Analysis
2.8.4 Merck Product and Services
2.8.5 Merck Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Retinal Drugs Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Retinal Drugs Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Retinal Drugs Manufacturer Market Share in 2019
3.3.2 Top 6 Retinal Drugs Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Retinal Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Retinal Drugs Sales and Market Share by Regions (2015-2020)
4.1.2 Global Retinal Drugs Revenue and Market Share by Regions (2015-2020)
4.2 North America Retinal Drugs Sales and Growth Rate (2015-2020)
4.3 Europe Retinal Drugs Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Retinal Drugs Sales and Growth Rate (2015-2020)
4.5 South America Retinal Drugs Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Retinal Drugs Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Retinal Drugs Sales, Revenue and Market Share by Country
5.1.1 North America Retinal Drugs Sales and Market Share by Country (2015-2020)
5.1.2 North America Retinal Drugs Revenue and Market Share by Country (2015-2020)
5.2 United States Retinal Drugs Sales and Growth Rate (2015-2020)
5.3 Canada Retinal Drugs Sales and Growth Rate (2015-2020)
5.4 Mexico Retinal Drugs Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Retinal Drugs Sales, Revenue and Market Share by Country
6.1.1 Europe Retinal Drugs Sales and Market Share by Country (2015-2020)
6.1.2 Europe Retinal Drugs Revenue and Market Share by Country (2015-2020)
6.2 Germany Retinal Drugs Sales and Growth Rate (2015-2020)
6.3 UK Retinal Drugs Sales and Growth Rate (2015-2020)
6.4 France Retinal Drugs Sales and Growth Rate (2015-2020)
6.5 Russia Retinal Drugs Sales and Growth Rate (2015-2020)
6.6 Italy Retinal Drugs Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Retinal Drugs Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Retinal Drugs Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Retinal Drugs Revenue and Market Share by Regions (2015-2020)
7.2 China Retinal Drugs Sales and Growth Rate (2015-2020)
7.3 Japan Retinal Drugs Sales and Growth Rate (2015-2020)
7.4 Korea Retinal Drugs Sales and Growth Rate (2015-2020)
7.5 India Retinal Drugs Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Retinal Drugs Sales and Growth Rate (2015-2020)
7.7 Australia Retinal Drugs Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Retinal Drugs Sales, Revenue and Market Share by Country
8.1.1 South America Retinal Drugs Sales and Market Share by Country (2015-2020)
8.1.2 South America Retinal Drugs Revenue and Market Share by Country (2015-2020)
8.2 Brazil Retinal Drugs Sales and Growth Rate (2015-2020)
8.3 Argentina Retinal Drugs Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Retinal Drugs Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Retinal Drugs Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Retinal Drugs Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Retinal Drugs Sales and Growth Rate (2015-2020)
9.3 Turkey Retinal Drugs Sales and Growth Rate (2015-2020)
9.4 Egypt Retinal Drugs Sales and Growth Rate (2015-2020)
9.5 South Africa Retinal Drugs Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Retinal Drugs Sales and Market Share by Type (2015-2020)
10.2 Global Retinal Drugs Revenue and Market Share by Type (2015-2020)
10.3 Global Retinal Drugs Price by Type (2015-2020)
11 Global Retinal Drugs Market Segment by Application
11.1 Global Retinal Drugs Sales Market Share by Application (2015-2020)
11.2 Global Retinal Drugs Revenue Market Share by Application (2015-2020)
11.3 Global Retinal Drugs Price by Application (2015-2020)
12 Market Forecast
12.1 Global Retinal Drugs Sales, Revenue and Growth Rate (2021-2025)
12.2 Retinal Drugs Market Forecast by Regions (2021-2025)
12.2.1 North America Retinal Drugs Market Forecast (2021-2025)
12.2.2 Europe Retinal Drugs Market Forecast (2021-2025)
12.2.3 Asia-Pacific Retinal Drugs Market Forecast (2021-2025)
12.2.4 South America Retinal Drugs Market Forecast (2021-2025)
12.2.5 Middle East & Africa Retinal Drugs Market Forecast (2021-2025)
12.3 Retinal Drugs Market Forecast by Type (2021-2025)
12.3.1 Global Retinal Drugs Sales Forecast by Type (2021-2025)
12.3.2 Global Retinal Drugs Market Share Forecast by Type (2021-2025)
12.4 Retinal Drugs Market Forecast by Application (2021-2025)
12.4.1 Global Retinal Drugs Sales Forecast by Application (2021-2025)
12.4.2 Global Retinal Drugs Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Retinal Drugs Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Retinal Drugs by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Retinal Drugs Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Bayer Basic Information, Manufacturing Base and Competitors
Table 8. Bayer Retinal Drugs Major Business
Table 9. Bayer Retinal Drugs Total Revenue (USD Million) (2017-2018)
Table 10. Bayer SWOT Analysis
Table 11. Bayer Retinal Drugs Product and Services
Table 12. Bayer Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. ThromboGenics Basic Information, Manufacturing Base and Competitors
Table 14. ThromboGenics Retinal Drugs Major Business
Table 15. ThromboGenics Retinal Drugs Total Revenue (USD Million) (2017-2018)
Table 16. ThromboGenics SWOT Analysis
Table 17. ThromboGenics Retinal Drugs Product and Services
Table 18. ThromboGenics Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Regeneron Basic Information, Manufacturing Base and Competitors
Table 20. Regeneron Retinal Drugs Major Business
Table 21. Regeneron Retinal Drugs Total Revenue (USD Million) (2017-2018)
Table 22. Regeneron SWOT Analysis
Table 23. Regeneron Retinal Drugs Product and Services
Table 24. Regeneron Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. F. Hoffmann-La Roche Basic Information, Manufacturing Base and Competitors
Table 26. F. Hoffmann-La Roche Retinal Drugs Major Business
Table 27. F. Hoffmann-La Roche Retinal Drugs Total Revenue (USD Million) (2017-2018)
Table 28. F. Hoffmann-La Roche SWOT Analysis
Table 29. F. Hoffmann-La Roche Retinal Drugs Product and Services
Table 30. F. Hoffmann-La Roche Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Teva Pharmaceutical Basic Information, Manufacturing Base and Competitors
Table 32. Teva Pharmaceutical Retinal Drugs Major Business
Table 33. Teva Pharmaceutical Retinal Drugs Total Revenue (USD Million) (2017-2018)
Table 34. Teva Pharmaceutical SWOT Analysis
Table 35. Teva Pharmaceutical Retinal Drugs Product and Services
Table 36. Teva Pharmaceutical Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Novartis Basic Information, Manufacturing Base and Competitors
Table 38. Novartis Retinal Drugs Major Business
Table 39. Novartis Retinal Drugs Total Revenue (USD Million) (2017-2018)
Table 40. Novartis SWOT Analysis
Table 41. Novartis Retinal Drugs Product and Services
Table 42. Novartis Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 43. Takeda Basic Information, Manufacturing Base and Competitors
Table 44. Takeda Retinal Drugs Major Business
Table 45. Takeda Retinal Drugs Total Revenue (USD Million) (2017-2018)
Table 46. Takeda SWOT Analysis
Table 47. Takeda Retinal Drugs Product and Services
Table 48. Takeda Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 49. Merck Basic Information, Manufacturing Base and Competitors
Table 50. Merck Retinal Drugs Major Business
Table 51. Merck Retinal Drugs Total Revenue (USD Million) (2017-2018)
Table 52. Merck SWOT Analysis
Table 53. Merck Retinal Drugs Product and Services
Table 54. Merck Retinal Drugs Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 55. Global Retinal Drugs Sales by Manufacturer (2018-2019) (K Units)
Table 56. Global Retinal Drugs Revenue by Manufacturer (2018-2019) (USD Million)
Table 57. Global Retinal Drugs Sales by Regions (2015-2020) (K Units)
Table 58. Global Retinal Drugs Sales Market Share by Regions (2015-2020)
Table 59. Global Retinal Drugs Revenue by Regions (2015-2020) (USD Million)
Table 60. North America Retinal Drugs Sales by Countries (2015-2020) (K Units)
Table 61. North America Retinal Drugs Sales Market Share by Countries (2015-2020)
Table 62. North America Retinal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 63. North America Retinal Drugs Revenue Market Share by Countries (2015-2020)
Table 64. Europe Retinal Drugs Sales by Countries (2015-2020) (K Units)
Table 65. Europe Retinal Drugs Sales Market Share by Countries (2015-2020)
Table 66. Europe Retinal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 67. Asia-Pacific Retinal Drugs Sales by Regions (2015-2020) (K Units)
Table 68. Asia-Pacific Retinal Drugs Sales Market Share by Regions (2015-2020)
Table 69. Asia-Pacific Retinal Drugs Revenue by Regions (2015-2020) (USD Million)
Table 70. South America Retinal Drugs Sales by Countries (2015-2020) (K Units)
Table 71. South America Retinal Drugs Sales Market Share by Countries (2015-2020)
Table 72. South America Retinal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 73. South America Retinal Drugs Revenue Market Share by Countries (2015-2020)
Table 74. Middle East & Africa Retinal Drugs Sales by Countries (2015-2020) (K Units)
Table 75. Middle East & Africa Retinal Drugs Sales Market Share by Countries (2015-2020)
Table 76. Middle East & Africa Retinal Drugs Revenue by Countries (2015-2020) (USD Million)
Table 77. Middle East & Africa Retinal Drugs Revenue Market Share by Countries (2015-2020)
Table 78. Global Retinal Drugs Sales by Type (2015-2020) (K Units)
Table 79. Global Retinal Drugs Sales Share by Type (2015-2020)
Table 80. Global Retinal Drugs Revenue by Type (2015-2020) (USD Million)
Table 81. Global Retinal Drugs Revenue Share by Type (2015-2020)
Table 82. Global Retinal Drugs Sales by Application (2015-2020) (K Units)
Table 83. Global Retinal Drugs Sales Share by Application (2015-2020)
Table 84. Global Retinal Drugs Sales Forecast by Regions (2021-2025) (K Units)
Table 85. Global Retinal Drugs Market Share Forecast by Regions (2021-2025)
Table 86. Global Retinal Drugs Sales Forecast by Type (2021-2025) (K Units)
Table 87. Global Retinal Drugs Market Share Forecast by Type (2021-2025)
Table 88. Global Retinal Drugs Sales Forecast by Application (2021-2025)
Table 89. Global Retinal Drugs Market Share Forecast by Application (2021-2025)
Table 90. Direct Channel Pros & Cons
Table 91. Indirect Channel Pros & Cons
Table 92. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Retinal Drugs Picture
Figure 2. Global Sales Market Share of Retinal Drugs by Type in 2019
Figure 3. Wet AMD Picture
Figure 4. Diabetic Retinopathy Picture
Figure 5. DME Picture
Figure 6. RVO Picture
Figure 7. Mcnv Picture
Figure 8. Retinal Drugs Sales Market Share by Application in 2018
Figure 9. Hospitial Picture
Figure 10. Clinicl Picture
Figure 11. Others Picture
Figure 12. Global Retinal Drugs Market Status and Outlook (2015-2025) (USD Million)
Figure 13. United States Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 14. Canada Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 15. Mexico Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Germany Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 17. France Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 18. UK Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Russia Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Italy Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 21. China Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Japan Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Korea Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 24. India Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Southeast Asia Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Australia Retinal Drugs Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 27. Brazil Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Egypt Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Saudi Arabia Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 30. South Africa Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 31. Turkey Retinal Drugs Revenue (Value) and Growth Rate (2015-2025)
Figure 32. Global Retinal Drugs Sales Market Share by Manufacturer in 2019
Figure 33. Global Retinal Drugs Revenue Market Share by Manufacturer in 2019
Figure 34. Top 3 Retinal Drugs Manufacturer (Revenue) Market Share in 2019
Figure 35. Top 6 Retinal Drugs Manufacturer (Revenue) Market Share in 2019
Figure 36. Key Manufacturer Market Share Trend
Figure 37. Global Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 38. Global Retinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 39. Global Retinal Drugs Revenue Market Share by Regions (2015-2020)
Figure 40. Global Retinal Drugs Revenue Market Share by Regions in 2018
Figure 41. North America Retinal Drugs Sales and Growth Rate (2015-2020)
Figure 42. Europe Retinal Drugs Sales and Growth Rate (2015-2020)
Figure 43. Asia-Pacific Retinal Drugs Sales and Growth Rate (2015-2020)
Figure 44. South America Retinal Drugs Sales and Growth Rate (2015-2020)
Figure 45. Middle East & Africa Retinal Drugs Sales and Growth Rate (2015-2020)
Figure 46. North America Retinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 47. North America Retinal Drugs Sales Market Share by Countries (2015-2020)
Figure 48. North America Retinal Drugs Sales Market Share by Countries in 2018
Figure 49. North America Retinal Drugs Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 50. North America Retinal Drugs Revenue Market Share by Countries in 2018
Figure 51. United States Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 52. Canada Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 53. Mexico Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 54. Europe Retinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 55. Europe Retinal Drugs Revenue Market Share by Countries (2015-2020)
Figure 56. Europe Retinal Drugs Revenue Market Share by Countries in 2019
Figure 57. Germany Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 58. UK Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 59. France Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 60. Russia Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 61. Italy Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 62. Asia-Pacific Retinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 63. Asia-Pacific Retinal Drugs Sales Market Share by Regions 2019
Figure 64. Asia-Pacific Retinal Drugs Revenue Market Share by Regions 2019
Figure 65. China Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Japan Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 67. Korea Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 68. India Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 69. Southeast Asia Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 70. South America Retinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 71. South America Retinal Drugs Sales Market Share by Countries in 2019
Figure 72. South America Retinal Drugs Revenue Market Share by Countries in 2019
Figure 73. Brazil Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 74. Argentina Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 75. Middle East and Africa Retinal Drugs Revenue and Growth Rate (2015-2020) (USD Million)
Figure 76. Middle East and Africa Retinal Drugs Sales Market Share by Countries in 2019
Figure 77. Middle East and Africa Retinal Drugs Revenue Market Share by Countries (2015-2020)
Figure 78. Middle East and Africa Retinal Drugs Revenue Market Share by Countries in 2019
Figure 79. Saudi Arabia Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Egypt Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 81. Turkey Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 82. South Africa Retinal Drugs Sales and Growth Rate (2015-2020) (K Units)
Figure 83. Global Retinal Drugs Sales and Growth Rate (2021-2025) (K Units)
Figure 84. Global Retinal Drugs Revenue and Growth Rate (2021-2025) (USD Million)
Figure 85. North America Sales Retinal Drugs Market Forecast (2021-2025) (K Units)
Figure 86. Europe Sales Retinal Drugs Market Forecast (2021-2025) (K Units)
Figure 87. Asia-Pacific Sales Retinal Drugs Market Forecast (2021-2025) (K Units)
Figure 88. South America Sales Retinal Drugs Market Forecast (2021-2025) (K Units)
Figure 89. Middle East & Africa Sales Retinal Drugs Market Forecast (2021-2025) (K Units)
Figure 90. Sales Channel: Direct Channel vs Indirect Channel
網膜バイオシミラーの世界市場 2020年：企業別・地域別・種類別・用途別市場予測 Market Overview The global Retinal Biosimilars market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinal Biosimilars marke…- 網膜剥離フックの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Retinal Detachment Hook market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinal Detachment Ho…
- 網膜剥離治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Retinal Detachment Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinal Detachme…
- 網膜ジストロフィー治療の世界市場 2020年：企業別、地域別、種類・用途別 Market Overview The global Retinal Dystrophy Treatment market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Retinal Dystrophy…
- 血漿由来薬物の世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Plasma Derived Drugs market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Plasma Derived Drugs mar…